Top

Annals of Surgical Oncology

Published in:

01-07-2008 | Bone and Soft Tissue Sarcomas

Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor

Author: Hamid Namazi

Published in: Annals of Surgical Oncology | Issue 7/2008

Excerpt

To the Editor …

Puri A, Agrawal MG, Shah M, et al. Giant cell tumor of bone in children and adolescents. J Pediatr Orthop 2007;27:635–9PubMed

Maki K, Harada T, Akiyami Y, et al. Giant cell tumor of the rib. Intern Med 2007;46:1151–2PubMedCrossRef

Kapoor SK, Jain V, Agrawal M, et al. Primary malignant giant cell tumor of bone: a series of three rare cases. J Surg Orthop Adv 2007;16:89–92PubMed

Gleason BC, Kleinman PK, Debelenko LV, et al. Novel karyotypes in giant cell-rich lesions of bone. Am J Surg Pathol 2007;31:926–32PubMedCrossRef

Jones KB, DeYoung BR, Morcuende JA, et al. Ethanol as a local adjuvant for giant cell tumor of bone. Iowa Orthop J 2006;26:69–76PubMedCrossRef

Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006;37:35–51PubMedCrossRef

Werner M. Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 2006;30:484–9PubMedCrossRef

Hu Y, Yu S. Gene expression of osteoprotegerin and osteoclast differentiation factor in giant cell tumor. Zhonghua Bing Li Xue Za Zhi 2002;31:128–31PubMed

Atkins GJ, Kostakis P, Vincent C, et al. RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 2006;21:1339–49PubMedCrossRef

10.

Hirai F, Nakayamada S, Okada Y, et al. Small GTPase Rho signaling is involved in beta1 integrin-mediated up-regulation of intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturation. Biochem Biophys Res Commun 2007;356:279–85PubMedCrossRef

11.

Desai B, Rogers MJ, Chellaiah MA. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 2007;6:18–21PubMedCrossRef

12.

Brazier H, Stephens S, Ory S, et al. Expression profile of RhoGTPases and RhoGEFs during RANKL-stimulated osteoclastogenesis: identification of essential genes in osteoclasts. J Bone Miner Res 2006;21:1387–98PubMedCrossRef

13.

Holbourn KP, Sutton JM, Shore C, et al. Molecular recognition of an ADP-ribosyl transferase; clostridium botulinum C3 exoenzyme. Proc Natl Acad Sci 2005;102:5357–62PubMedCrossRef

14.

Harmey D, Stenbeck G, Nobes CD, et al. Regulation of osteoblast differentiation by Pasteurella multocida toxin (PMT): a role for Rho GTPase in bone formation. J Bone Miner Res 2004;19:661–7PubMedCrossRef

15.

Singh R, Wang B, Shirraikar A, et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 1999;103:1561–70PubMedCrossRef

Title: Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor
Author: Hamid Namazi
Publication date: 01-07-2008
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 7/2008
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-007-9770-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Botulinum Toxin: A Novel Adjuvant for Giant Cell Tumor

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2008

Cancer Clinical Trials Accrual: Missed Opportunities to Address Disparities and Missed Opportunities to Improve Outcomes for All

Can Intraoperative Intraperitoneal Free Cancer Cell Detection Techniques Identify Patients at Higher Recurrence Risk Following Curative Colorectal Cancer Resection? A Meta-Analysis

Multivariate Analysis of the Pathologic Features of Esophageal Squamous Cell Cancer: Tumor Budding Is a Significant Independent Prognostic Factor

Squamous Cell Carcinoma of the Anal Canal: Utilization and Outcomes of Recommended Treatment in the United States

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

A Prospective, Blinded Trial of Touch Prep Analysis versus Frozen Section for Intraoperative Evaluation of Sentinel Lymph Nodes in Breast Cancer